SUBSCRIPTION AGREEMENTSubscription Agreement • April 8th, 2021 • Odyssey Semiconductor Technologies, Inc. • Semiconductors & related devices • New York
Contract Type FiledApril 8th, 2021 Company Industry JurisdictionThis Subscription Agreement (this “Agreement”) has been executed by the purchaser set forth on the signature page hereof (the “Purchaser”) in connection with the private placement offering (the “Offering”) by Odyssey Semiconductor Technologies, Inc., a Delaware corporation (the “Company”).
SUBSCRIPTION AGREEMENTSubscription Agreement • December 30th, 2020 • Transphorm, Inc. • Semiconductors & related devices • New York
Contract Type FiledDecember 30th, 2020 Company Industry JurisdictionThis Subscription Agreement (this “Agreement”) has been executed by the purchaser set forth on the signature page hereof (the “Purchaser”) and Transphorm, Inc., a Delaware corporation (the “Company” or “Transphorm”) in connection with the private placement offering (the “Offering”) by the Company of shares (the “Shares”) of the Company’s common stock, par value $0.0001 per share (“Common Stock”), at a purchase price of $3.00 per share (the “Purchase Price”).
SUBSCRIPTION AGREEMENTSubscription Agreement • December 30th, 2020 • Transphorm, Inc. • Semiconductors & related devices • New York
Contract Type FiledDecember 30th, 2020 Company Industry JurisdictionThis Subscription Agreement (this “Agreement”) has been executed by the purchaser set forth on the signature page hereof (the “Purchaser”) and Transphorm, Inc., a Delaware corporation (the “Company” or “Transphorm”) in connection with the private placement offering (the “Offering”) by the Company of shares (the “Shares”) of the Company’s common stock, par value $0.0001 per share (“Common Stock”), at a purchase price of $3.00 per share (the “Purchase Price”).
SUBSCRIPTION AGREEMENTSubscription Agreement • June 2nd, 2020 • Wrap Technologies, Inc. • Ordnance & accessories, (no vehicles/guided missiles) • Delaware
Contract Type FiledJune 2nd, 2020 Company Industry JurisdictionThis Subscription Agreement (this “Agreement”) has been executed by the purchaser set forth on the signature page hereof (the “Purchaser”) in connection with a registered direct public offering (the “Offering”) by Wrap Technologies, Inc., a Delaware corporation (the “Company”).
SUBSCRIPTION AGREEMENTSubscription Agreement • August 21st, 2019 • Amesite Inc. • Services-prepackaged software • New York
Contract Type FiledAugust 21st, 2019 Company Industry JurisdictionThis Subscription Agreement (this “Agreement”) has been executed by the purchaser set forth on the signature page hereof (the “Purchaser”) in connection with the private placement offering (the “Offering”) by Amesite Inc., a Delaware corporation (the “Company”).
SUBSCRIPTION AGREEMENTSubscription Agreement • June 18th, 2019 • Wrap Technologies, Inc. • Ordnance & accessories, (no vehicles/guided missiles) • Delaware
Contract Type FiledJune 18th, 2019 Company Industry JurisdictionThis Subscription Agreement (this “Agreement”) has been executed by the purchaser set forth on the signature page hereof (the “Purchaser”) in connection with a registered direct public offering (the “Offering”) by Wrap Technologies, Inc., a Delaware corporation (the “Company”).
SUBSCRIPTION AGREEMENTSubscription Agreement • November 5th, 2018 • Wrap Technologies, Inc. • Ordnance & accessories, (no vehicles/guided missiles) • Delaware
Contract Type FiledNovember 5th, 2018 Company Industry JurisdictionThis Subscription Agreement (this “Agreement”) has been executed by the purchaser set forth on the signature page hereof (the “Purchaser”) in connection with the private placement offering (the “Offering”) by Wrap Technologies, Inc., a Delaware corporation (the “Company”).
FORM OF SUBSCRIPTION AGREEMENTSubscription Agreement • August 28th, 2018 • Exicure, Inc. • Pharmaceutical preparations • New York
Contract Type FiledAugust 28th, 2018 Company Industry JurisdictionThis Subscription Agreement (this “Agreement”) has been executed by the purchaser set forth on the signature page hereof (the “Purchaser”) in connection with the private placement offering (the “Offering”) by Exicure, Inc., a Delaware corporation (the “Company”).
FORM OF SUBSCRIPTION AGREEMENTSubscription Agreement • November 2nd, 2017 • Exicure, Inc. • Pharmaceutical preparations • New York
Contract Type FiledNovember 2nd, 2017 Company Industry Jurisdiction
FORM OF SUBSCRIPTION AGREEMENTSubscription Agreement • October 2nd, 2017 • Exicure, Inc. • Blank checks • New York
Contract Type FiledOctober 2nd, 2017 Company Industry JurisdictionThis Subscription Agreement (this “Agreement”) has been executed by the purchaser set forth on the signature page hereof (the “Purchaser”) in connection with the private placement offering (the “Offering”) by Max-1 Acquisition Corporation (to be renamed “Exicure, Inc.” upon consummation of the Merger (as defined below)), a Delaware corporation (the “Company”).
SUBSCRIPTION AGREEMENTSubscription Agreement • September 25th, 2017 • Sincerity Applied Materials Holdings Corp. • Services-business services, nec • New York
Contract Type FiledSeptember 25th, 2017 Company Industry JurisdictionThis Subscription Agreement (this “Agreement”) has been executed by the purchaser set forth on the signature page hereof (the “Purchaser”) in connection with the private placement offering (the “Offering”) by Sincerity Applied Materials Holdings Corp. (f/k/a Symbid Corp.), a Nevada corporation (the “Company” or “SAMHC”) of a minimum of $150,000 (the “Minimum Offering”) and a maximum of $500,000 (the “Maximum Offering”) of units of securities (the “Units”), at a purchase price of $10,000 per Unit (the “Purchase Price”). Each Unit consists of (i) one 12% Senior Secured Convertible Promissory Note with a term of 13 months in the face (principal) amount of $10,000, substantially in the form of Exhibit A hereto (the “Note”) and (ii) one warrant substantially in the form of Exhibit B hereto (the “Warrant”) exercisable for a period of five (5) years from issuance representing the right to purchase shares of common stock of the Company, $0.001 par value per share (the “Common Stock”), at the e
SUBSCRIPTION AGREEMENTSubscription Agreement • March 17th, 2017 • Aerpio Pharmaceuticals, Inc. • Blank checks • New York
Contract Type FiledMarch 17th, 2017 Company Industry Jurisdiction* For purposes of calculating your net worth in this form, (a) your primary residence shall not be included as an asset; (b) indebtedness secured by your primary residence, up to the estimated fair market value of your primary residence at the time of your purchase of the securities, shall not be included as a liability (except that if the amount of such indebtedness outstanding at the time of your purchase of the securities exceeds the amount outstanding sixty (60) days before such time, other than as a result of the acquisition of your primary residence, the amount of such excess shall be included as a liability); and (c) indebtedness that is secured by your primary residence in excess of the estimated fair market value of your primary residence at the time of your purchase of the securities shall be included as a liability.